Healthcare provider profile · identity verified

Geraldine Zabik, M.D.

Internal Medicine · NEWTON LOWER FALLS, MA · NPI 1063594828

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	518	158
Levothyroxine Sodium	Levothyroxine Sodium	292	79
Amlodipine Besylate	Amlodipine Besylate	271	80
Lisinopril	Lisinopril	211	65
Rosuvastatin Calcium	Rosuvastatin Calcium	179	58
Sertraline Hcl	Sertraline Hcl	143	41
Hydrochlorothiazide	Hydrochlorothiazide	133	44
Losartan Potassium	Losartan Potassium	110	39
Omeprazole	Omeprazole	104	37
Metoprolol Succinate	Metoprolol Succinate	90	26
Gabapentin	Gabapentin	89	21
Lorazepam	Lorazepam	88	35
Pravastatin Sodium	Pravastatin Sodium	88	25
Simvastatin	Simvastatin	83	21
Atenolol	Atenolol	82	25
Trazodone Hcl	Trazodone Hcl	82	21
Eliquis	Apixaban	78	15
Clonazepam	Clonazepam	58	11
Alendronate Sodium	Alendronate Sodium	53	19
Escitalopram Oxalate	Escitalopram Oxalate	50	20
Pantoprazole Sodium	Pantoprazole Sodium	50	13
Citalopram Hbr	Citalopram Hydrobromide	48	14
Fluoxetine Hcl	Fluoxetine Hcl	47	11
Zolpidem Tartrate	Zolpidem Tartrate	46	16
Metformin Hcl	Metformin Hcl	44	13
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	44	28
Bupropion Xl	Bupropion Hcl	43	suppressed
Prednisone	Prednisone	43	17
Ezetimibe	Ezetimibe	42	13
Valacyclovir	Valacyclovir Hcl	42	18
Potassium Chloride	Potassium Chloride	41	14
Valsartan	Valsartan	41	15
Furosemide	Furosemide	40	12
Tamsulosin Hcl	Tamsulosin Hcl	38	suppressed
Tramadol Hcl	Tramadol Hcl	37	suppressed
Nystatin	Nystatin	35	12
Oxycodone Hcl	Oxycodone Hcl	35	suppressed
Hydrocortisone	Hydrocortisone	32	11
Synthroid	Levothyroxine Sodium	30	suppressed
Famotidine	Famotidine	29	suppressed
Estradiol	Estradiol	26	suppressed
Wegovy	Semaglutide	26	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	25	24
Arnuity Ellipta	Fluticasone Furoate	25	suppressed
Fluticasone Propionate	Fluticasone Propionate	25	11
Venlafaxine Hcl Er	Venlafaxine Hcl	24	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	23	18
Albuterol Sulfate Hfa	Albuterol Sulfate	22	12
Azithromycin	Azithromycin	22	19
Alprazolam	Alprazolam	21	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	21	suppressed
Amoxicillin	Amoxicillin	20	16
Metoprolol Tartrate	Metoprolol Tartrate	20	suppressed
Clopidogrel	Clopidogrel Bisulfate	18	suppressed
Metformin Hcl Er	Metformin Hcl	18	suppressed
Propranolol Hcl Er	Propranolol Hcl	18	suppressed
Carvedilol	Carvedilol	17	suppressed
Ibuprofen	Ibuprofen	17	suppressed
Olanzapine	Olanzapine	17	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	17	suppressed
Azelastine Hcl	Azelastine Hcl	15	suppressed
Klor-Con M10	Potassium Chloride	15	suppressed
Baclofen	Baclofen	14	suppressed
Donepezil Hcl	Donepezil Hcl	14	suppressed
Methenamine Hippurate	Methenamine Hippurate	14	suppressed
Allopurinol	Allopurinol	13	suppressed
Enalapril Maleate	Enalapril Maleate	13	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	13	suppressed
Repatha Sureclick	Evolocumab	13	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	13	suppressed
Warfarin Sodium	Warfarin Sodium	13	suppressed
Diazepam	Diazepam	12	suppressed
Duloxetine Hcl	Duloxetine Hcl	12	suppressed
Memantine Hcl	Memantine Hcl	12	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	12	suppressed
Primidone	Primidone	12	suppressed
Trulicity	Dulaglutide	12	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	11	suppressed
Finasteride	Finasteride	11	suppressed
Klonopin	Clonazepam	11	suppressed
Methadone Hcl	Methadone Hcl	11	suppressed
Methylphenidate Er	Methylphenidate Hcl	11	suppressed
Paroxetine Hcl	Paroxetine Hcl	11	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error